Red cell transfusion and alloimmunization in sickle cell disease.

Area of Science:

• Hematology
• Transfusion Medicine
• Sickle Cell Disease Management

Background:

• Red cell transfusion is essential for managing acute and chronic sickle cell disease complications.
• Evidence supports transfusion for preventing strokes and acute chest syndrome.
• Expert consensus guides transfusion for specific conditions like splenic sequestration and acute stroke.

Purpose of the Study:

• To review transfusion methods, indications, and complications in sickle cell disease.
• To emphasize the significant issue of alloimmunization in transfusion therapy.

Main Methods:

• Review of randomized clinical trials and expert consensus recommendations.
• Discussion of adverse effects, including alloimmunization, hemolytic reactions, and iron overload.
• Exploration of strategies to minimize adverse effects, such as antigen matching and iron chelation.

Main Results:

• Transfusion therapy is proven effective for stroke prevention and managing acute chest syndrome.
• Adverse effects of transfusion, particularly alloimmunization, are common in sickle cell disease.
• Strategies like optimized antigen matching and iron chelation can mitigate transfusion risks.

Conclusions:

• Judicious use of red cell transfusions is crucial for sickle cell disease care.
• Minimizing adverse effects requires careful patient selection, optimized matching, and specific interventions.
• Early recognition and management of transfusion reactions are key to preventing poor outcomes.